Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07544290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autoimmune Hyperthyroidism in Prepubertal Children

Study acronym: IPER6
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
The investigators propose a multicenter retrospective study to assess clinical, biochemical, and auxological characteristics at diagnosis and during follow-up in a cohort of Caucasian pediatric patients diagnosed with autoimmune hyperthyroidism before puberty. These prepubertal patients will be compared with a control group of post-pubertal patients with Graves' disease. This study aims to enhance the understanding of autoimmune hyperthyroidism in prepubertal patients by providing a detailed evaluation of disease onset, therapeutic response, and growth-related outcomes. The inclusion of a carefully matched post-pubertal control group will allow for robust comparative analysis and identification of age-dependent clinical patterns and prognostic indicators, ultimately supporting more tailored and effective management strategies in pediatric populations at this particular age.
Trial Details
NCT Number NCT07544290
Lead Sponsor IRCCS Ospedale San Raffaele
Collaborators: University of Campania Luigi Vanvitelli, University of Genova, S. Anna Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Azienda Ospedaliero-Universitaria di Parma, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Azienda Ospedaliera Universitaria Integrata Verona, Fondazione IRCCS San Gerardo dei Tintori, Azienda Ospedaliera Universitaria Policlinico "G. Martino", Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria, Università di Torino, Torino, Federico II University, Buzzi Children's Hospital
Conditions
(from sponsor)
Autoimmune Hyperthyroidism, Children
Related terms Graves Disease
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov